You are a running a promising Canadian life science start-up and seeking funding. You have access to incentives in Canada but need to consider additional options. The market and resources outside of Canada—specifically in the USA--are a natural target. While you proudly aspire to "Made in Canada" solutions, there are funding realities that might need to be addressed on the path to global commercialization of exceptional Canadian technologies.
On September 10, we’ll discuss the game plan that can help you overcome these challenges:
- Available funding in Canada for current and future rounds to potentially finance your company
- Obligations, as a Canadian incorporated company, to your current Canadian investors (i.e. grants, tax credits, institutions, financial institutions, government)
- Overcoming US potential investors’ objections to invest in non-US companies
- Logistics and costs to incorporate as a US company
- Immigration under the current business and political environment
- Banking needs
And more…
This session will bring together experts from key disciplines who will share best practices and examples to help you determine the optimal road map for your Canadian life science company.
This program is also available via webinar.
Agenda
4:00 pm - 4:30 pm: Registration Opens, Networking & Introductions
4:30 pm - 4:35 pm: Opening Remarks
4:35 pm - 4:50 pm: Optimizing Cross-Border Structure
4:50 pm - 5:00 pm: Immigration Issues, Options and Actions
5:00 pm - 5:10 pm: Optimizing Tax Structures
5:10 pm - 5:15 pm: Break
5:15 pm - 6:00 pm: Panel Discussion
6:00 pm - 6:15 pm: Q&A
6:15 pm - 7:00 pm: Networking
7:00 pm Program Close
Speakers & MODERATOR
Sonia Yung - General Counsel -- Moderator
Bloom Burton
Sonia Yung is the General Counsel of Bloom Burton & Co. with over 25 years of legal experience, practicing securities and corporate law. Sonia was formerly a partner at Baker McKenzie and head of its Toronto Corporate and Securities Group. Sonia was also a member of Baker McKenzie’s global healthcare industry group with a particular focus on cross-border capital markets transactions in the healthcare sector. Sonia has been recognized by The Best Lawyers in Canada (Woodward/White) as a leading lawyer in Securities Law (2011 to 2017) and as a Leading Practitioner for Corporate Finance (2018 Canadian Legal Expert® Directory).
Ron looks forward to helping your business improve while assisting to change the lives of your company's employees for the better.
Brian Appel - Associate, Corporate
Wilson Sonsini Goodrich & Rosati
Brian Appel is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
Prior to joining the firm, Brian was an associate at Seyfarth Shaw LLP, where he was a member of the corporate practice group and technology transactions team.
Pavan Dhillon - Canadian Immigration Attorney
Dhillon Immigration Law
Born and educated in Canada, Pavan immigrated to the United States where she successfully managed and shaped the largest Canadian immigration practices in the country. Specifically, she led the Canadian immigration practice for Seyfarth Shaw LLP, a leading Am100 law firm with offices across the United States, the United Kingdom, Australia and China. While serving as the lead Canadian immigration lawyer for not only multinational Fortune 500 companies, she devised immigration strategies with a compliance-driven approach. She regularly provides legal expertise to regional companies and startups seeking to expand into the Canadian market.
She has successfully facilitated over a thousand Canadian immigration applications including both corporate and employment-based applications as well as personal, study-based or family-based sponsorship applications.
Lee Johnson - Associate, Intellectual Property
Wilson Sonsini Goodrich & Rosati
Dr. Lee A. Johnson is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where he provides counsel and assistance to clients in intellectual property matters, including patent counseling, drafting, and prosecution.
Lee also represents clients in IP disputes before the courts and before the U.S. Patent and Trademark Office (USPTO), and he regularly acts on behalf of both investors and growth-stage innovative companies and transactional IP counsel in licensing and technology transfer matters, research collaborations and partnerships, initial public offerings (IPOs), mergers, and acquisitions.
Lee represents clients from a range of industries, including biotechnology, pharmaceuticals, medical devices, and agriculture and food technologies.
Before joining WSGR, Lee practiced IP law with a major Canadian-based international law firm. He is fluent in English and French.
Tony Maddalena - Partner, National Business Tax Leader
Deloitte
Ron Matten - Founder
Matten Law
With nearly 25 years of total experience as both an engineer and a lawyer, Ron brings a unique and fresh perspective to the practice of business immigration law. With several years experience with a large engineering company and more than a decade with the Big 4, Ron understands what you do and how you do it.
Applying technology, automation and principles of continuous improvement to a solid base of legal knowledge and experience to optimize both the immigration process and the end user experience.
For more than 15 years, Ron has built and led immigration teams - serving 3 of the Top 25 PERM filers - by always striving for excellence for both the corporate client and the foreign-national applicant. Ron was at the forefront of innovative solutions for today's mobile workforce, handling a number of successful PERM appeals and developing robust preparation methods, all while instilling the value of top notch client service to his teams.
Ron looks forward to helping your business improve while assisting to change the lives of your company's employees for the better.
Michael Scott - Senior Vice President, Product Development/Toronto Operations
BlueRock Therapeutics
Michael Scott joined BlueRock in 2017 to oversee the company’s product realization processes and Toronto operations. In this role, he is a key part of the team focused on cell therapy product development including cell processes, assay development and delivery devices for dopaminergic neurons to treat Parkinson’s disease and cardiomyocytes to treat congestive heart failure. Prior to joining BlueRock, Dr. Scott served as chief development officer & vice president of R&D at ViaCyte, a clinical-stage biotechnology company focused on the treatment of type I diabetes with a stem cell-based therapy product.
He received a Ph.D. in medical biophysics from The University of Western Ontario, and masters and bachelor’s degrees in civil engineering from the University of Waterloo.
REGISTER HERE
